Publicaciones en colaboración con investigadores/as de Hôpital Européen Georges-Pompidou (23)

2024

  1. A Mouse Model of Hepatocellular Carcinoma Induced by Streptozotocin and High-Fat Diet

    Methods in molecular biology (Clifton, N.J.), Vol. 2769, pp. 67-75

  2. A Mouse Model of Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma Induced by Western Diet and Carbon Tetrachloride

    Methods in molecular biology (Clifton, N.J.), Vol. 2769, pp. 57-65

  3. Acyl-CoA binding protein for the experimental treatment of anorexia

    Science translational medicine, Vol. 16, Núm. 760, pp. eadl0715

  4. Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non‐Small‐Cell Lung Cancer

    Clinical Lung Cancer, Vol. 25, Núm. 3, pp. 233-243.e8

  5. Biomarker Identification in Liver Cancers Using Desorption Electrospray Ionization Mass Spectrometry (DESI-MS) Imaging: An Approach for Spatially Resolved Metabolomics

    Methods in molecular biology (Clifton, N.J.), Vol. 2769, pp. 199-209

  6. Impact of Aficamten on Disease and Symptom Burden in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM

    Journal of the American College of Cardiology, Vol. 84, Núm. 19, pp. 1821-1831

  7. Inhibition of acyl-CoA binding protein (ACBP) by means of a GABAARγ2-derived peptide

    Cell Death and Disease, Vol. 15, Núm. 4

  8. Orthotopic Model of Hepatocellular Carcinoma in Mice

    Methods in molecular biology (Clifton, N.J.), Vol. 2769, pp. 1-13

  9. Targeted Analysis of Glycerophospholipids and Mono-, Di-, or Tri-Acylglycerides in Liver Cancer

    Methods in molecular biology (Clifton, N.J.), Vol. 2769, pp. 189-198

2023

  1. Association between common cardiovascular risk factors and clinical phenotype in patients with hypertrophic cardiomyopathy from the European Society of Cardiology (ESC) EurObservational Research Programme (EORP) Cardiomyopathy/Myocarditis registry

    European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 9, Núm. 1, pp. 42-53

  2. Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer

    Lung Cancer, Vol. 178, pp. 116-122

2021

  1. Cardiac Involvement in Fabry Disease: JACC Review Topic of the Week

    Journal of the American College of Cardiology, Vol. 77, Núm. 7, pp. 922-936

  2. Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: Observational study using prospectively collected registry data

    BMJ, Vol. 375

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  4. Prospective follow-up in various subtypes of cardiomyopathies: Insights from the ESC EORP Cardiomyopathy Registry

    European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 7, Núm. 2, pp. 134-142

2018

  1. Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals

    Clinical Microbiology and Infection, Vol. 24, Núm. 10, pp. 1070-1076

2017

  1. Cardiac allograft vasculopathy

    The Pathology of Cardiac Transplantation: A Clinical and Pathological Perspective (Springer International Publishing), pp. 279-305

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. European cardiomyopathy pilot registry: EURObservational research programme of the European society of cardiology

    European Heart Journal, Vol. 37, Núm. 2, pp. 164-173

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222